Identification of frequent cytogenetic aberrations in hepatocellular carcinoma using gene-expression microarray data
Open Access
- 25 November 2002
- journal article
- research article
- Published by Springer Nature in Genome Biology
Abstract
Hepatocellular carcinoma (HCC) is a leading cause of death worldwide. Frequent cytogenetic abnormalities that occur in HCC suggest that tumor-modifying genes (oncogenes or tumor suppressors) may be driving selection for amplification or deletion of these particular genetic regions. In many cases, however, the gene(s) that drive the selection are unknown. Although techniques such as comparative genomic hybridization (CGH) have traditionally been used to identify cytogenetic aberrations, it might also be possible to identify them indirectly from gene-expression studies. A technique we have called comparative genomic microarray analysis (CGMA) predicts regions of cytogenetic change by searching for regional gene-expression biases. CGMA was applied to HCC gene-expression profiles to identify regions of frequent cytogenetic change and to identify genes whose expression is misregulated within these regions. Using CGMA, 104 HCC gene-expression microarray profiles were analyzed. CGMA identified 13 regions of frequent cytogenetic change in the HCC samples. Ten of these regions have been detected in previous CGH studies (+lq, -4q, +6p, -8p, +8q, -13q, -16q, -17p, +17q, +20q). CGMA identified three additional regions that have not been previously identified by CGH (+5q, +12q, +19p). Genes located in regions of frequent cytogenetic change were examined for changed expression in the HCC samples. Our results suggest that CGMA predictions using gene-expression microarray datasets are a practical alternative to CGH profiling. In addition, CGMA might be useful for identifying candidate genes within cytogenetically abnormal regions.Keywords
This publication has 37 references indexed in Scilit:
- TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomasHepatology, 2002
- Comparative genomic hybridization of hepatocellular carcinoma: Correlation with fluorescence in situ hybridization in paraffin-embedded tissueMolecular Diagnosis, 2001
- Comparative Genomic Hybridization of Hepatocellular Carcinoma: Correlation With Fluorescence In Situ Hybridization in Paraffin-embedded TissueMolecular Diagnosis, 2001
- Evaluation of the Reliability of Chromosomal Imbalances Detected by Combined Use of Universal DNA Amplification and Comparative Genomic HybridizationJapanese Journal of Cancer Research, 2000
- Genetic Aberrations Detected by Comparative Genomic Hybridization in Hepatocellular Carcinomas: Their Relationship to Clinicopathological FeaturesHepatology, 1999
- Novel Recurrent Genetic Imbalances in Human Hepatocellular Carcinoma Cell Lines Identified by Comparative Genomic HybridizationHepatology, 1999
- Assessment of Genetic Changes in Hepatocellular Carcinoma by Comparative Genomic Hybridization AnalysisThe American Journal of Pathology, 1999
- Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burdenInternational Journal of Cancer, 1993
- Estimates of the worldwide incidence of eighteen major cancers in 1985International Journal of Cancer, 1993
- Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid TumorsScience, 1992